Valuation : AstraZeneca PLC

Market Cap 252B 1,290B 217B 204B 186B 348B 23,773B 349B 2,409B 935B 12,197B 945B 925B 39,293B P/E 2026 *
20.9x
P/E 2027 * 18.3x
Enterprise Value 271B 1,390B 233B 220B 201B 375B 25,610B 376B 2,595B 1,007B 13,140B 1,019B 996B 42,330B EV / Sales 2026 *
4.29x
EV / Sales 2027 * 3.94x
Free-Float
96.63%
Yield 2026 *
2.06%
Yield 2027 * 2.19%
1 day-0.24%
1 week-1.05%
Current month-0.80%
1 month+1.62%
3 months-12.80%
6 months-18.39%
Current year-17.34%
1 week 137.21
Extreme 137.21
141.39
1 month 133.75
Extreme 133.75
145.6
Current year 130.06
Extreme 130.06
190.4
1 year 130.02
Extreme 130.02
190.4
3 years 101.6
Extreme 101.6
190.4
5 years 93.74
Extreme 93.74
190.4
10 years 93.74
Extreme 93.74
190.4
Manager TitleAgeSince
Chief Executive Officer 66 2012-09-30
Director of Finance/CFO 52 2021-07-31
Compliance Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 66 2012-09-30
Director/Board Member 65 2017-04-26
Change 5-day change 1-year change 3-year change Capi.($)
-0.24%-1.05% - - 252B
-0.88%-2.15%+58.05%+105.26% 1,024B
-1.15%+2.68%+54.25%+74.19% 663B
-1.44%+0.38%+20.65%+76.13% 453B
-0.91%+0.48%+31.25%+38.13% 352B
-2.61%+2.73%+23.75%+42.86% 304B
+0.53%+1.25%+1.19%+11.90% 252B
-1.55%+1.11%+54.15%+75.59% 236B
-0.17%+2.22%-13.85%-55.80% 206B
-0.15%+3.65%+31.24%+103.39% 187B
Average -0.85%+1.26%+28.96%+52.40% 408.71B
Weighted average by Cap. -0.96%+0.62%+37.83%+67.09%

Financials

2026 *2027 *
Net sales 63.28B 324B 54.45B 51.23B 46.8B 87.55B 5,975B 87.79B 605B 235B 3,065B 238B 232B 9,875B 66.87B 343B 57.54B 54.13B 49.45B 92.51B 6,313B 92.76B 640B 248B 3,239B 251B 246B 10,435B
Net income 12.02B 61.58B 10.34B 9.73B 8.89B 16.63B 1,135B 16.67B 115B 44.62B 582B 45.13B 44.14B 1,875B 13.7B 70.2B 11.79B 11.09B 10.13B 18.96B 1,294B 19.01B 131B 50.86B 664B 51.45B 50.33B 2,138B
Net Debt 19.46B 99.72B 16.75B 15.76B 14.39B 26.93B 1,838B 27B 186B 72.25B 943B 73.08B 71.49B 3,037B 11.79B 60.4B 10.14B 9.54B 8.72B 16.31B 1,113B 16.35B 113B 43.76B 571B 44.27B 43.3B 1,840B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-09-04 R$139.42 -0.24% 2,553
26-09-03 R$139.76 +1.32% 7,311
26-09-02 R$137.94 -1.33% 124
26-09-01 R$139.80 -0.53% 26
26-08-31 R$140.55 -0.25% 120
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
162.34USD
Average target price
212.94USD
Spread / Average Target
+31.17%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!